Discipline in genetics
POPULARITY
Categories
The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Welcome back to another episode of Brands and Barbed Wire. This week we continue our Future of Beef series where we interview Nick Jorgensen with Jorgensen Land and Cattle. We've interviewed the Jorgensen family before here on Brands and Barbed Wire which is an incredible episode if you haven't listened. It's about the family's history in the Angus business and details the famous FBI raid on the ranch. This episode from the Future of Beef focuses more on the technology they utilize on their ranch in SD. We hope you enjoy the show and more information on the Future of Beef visit www.thefutureofbeef.com. Thanks to our sponsors Allied Genetic Resources www.alliedgeneticresources.com, The Grant Company at www.grantcompany.net, B.R. Cutrer Ranch www.brcutrer.com, Jorgensen Land and Cattle www.jorgensenfarms.com
In this episode of the AgCulture Podcast, Eric McNeilly, International Premier Account Manager at Alta Genetics, shares insights from his 49-year career in the global dairy industry. From managing herds of over 20,000 cows to restructuring troubled farms across six continents, Eric explains the systems, cultural dynamics, and technologies driving efficient dairy operations. Learn practical management strategies and how to future-proof your dairy business. Listen now on all major platforms!Meet the guest: Eric McNeilly has nearly five decades of experience in the dairy industry, including managing herds of over 200,000 cows and consulting across 22 countries. With deep expertise in labor efficiency, dairy systems, and genetics, he now serves as International Premier Account Manager at Alta Genetics.What you will learn: (00:00) Introduction(05:11) Managing large herds(14:11) Cross-cultural leadership(15:31) Farm restructuring systems(24:15) Genomics in breeding(28:23) Technology in dairy(37:01) Closing thoughtsDiscover the world of agriculture with the "Ag Culture Podcast". This podcast will be a gateway for those passionate about agriculture to explore its global perspectives and innovative practices.Join Paul as he shares his experiences in the agricultural industry, his travels and encounters with important figures around the world.Available on YouTube, Spotify and Apple Podcasts.Subscribe at http://www.agculturepodcast.com and keep an eye out for future episodes, bringing insights and stories from the vibrant world of agriculture.
HIV, superbugs, and standards—oh my! In this episode of Absolute Gene-ius, we explore the frontier of infectious disease research with Dr. Jesús Mingorance, researcher at Hospital Universitario La Paz in Madrid. His research is translational and uses digital PCR, qPCR, sequencing, and more.Dr. Mingorance walks us through his application of ultra-sensitive PCR methods to track HIV-2 viral loads—particularly in challenging cases where standard assays fall short. He shares how digital PCR enabled detection in samples where conventional tests failed, and how it's becoming essential for assay calibration and microbial quantification. He also dives into the endemic challenges of carbapenem-resistant Klebsiella pneumoniae in hospitals, revealing the clinical and epidemiological importance of quantifying pathogen load within the microbiome.In the career corner, Dr. Mingorance recounts his unconventional journey—from humanities student to biologist inspired by a single sentence about DNA. With humor and honesty, he reflects on the patience needed in science, the value of good questions, and the importance of mentoring new scientists. “Biology is beautiful,” he reminds us. We agree.Visit the Absolute Gene-ius pageto learn more about the guests, the hosts, and the Applied Biosystems QuantStudio Absolute Q Digital PCR System.
The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Watch my first-ever conversation with a political leader on the Alloutcoach show who has also transcended business, entrepreneurship, community service, women's rights advocacy and sports science. This episode uncovers a personal story and manifestation of character and integrity of an inspiring, dynamic, and powerful leader, Hon. Leela Aheer, former Canadian Minister of Culture, Multiculturalism, and Women's rights, musician, and activist throughout her journey of transformation into becoming a business executive, entrepreneur and expert in optimizing athletic performance.In addition to lessons on sportsmanship-centered leadership in business, you will discover the difference precision medicine with multi-omics and slightest variance in our microbiome DNA can have on creating gold medalists in sports, and champions in health, training, rehabilitation and recovery.
Did you know that breastfeeding may be the “biological norm,” but it is a learned skill for both mothers and babies. Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Jennifer Smilowitz, Ph.D., Assistant Professor of Cooperative Extension in the Department of Nutrition, at the U. of CA, Davis, and Director of Scientific and Strategic Development for the International Milk Genomics Consortium. Smilowitz will discuss the multiple benefits of breastfeeding for maternal, child and planetary health, the policies needed to support breastfeeding, and how breast milk uniquely protects infants' health as well as contributes to sustainability and community resilience. Note: August is World Breastfeeding MonthRelated Websites: https://www.milkgenomics.org/splash/
In this episode of Beyond the Thesis with Papa PhD, host David Mendes sits down with Dr. Karina do Santos Machado, a trailblazing young scientist from Brazil whose journey exemplifies the power of collaboration and open science in the global South. Karina shares her path from a childhood fascination with computers to becoming a principal investigator leading cutting-edge drug discovery research with global impact, all from her home base in Rio Grande. Facing the challenges of limited funding, infrastructure hurdles, and fewer resources common to universities in developing countries, Karina highlights how resourcefulness and community spirit have been fundamental to her success. Collaboration is not only a choice but a necessity in the Brazilian scientific landscape. By building networks both within her institution and internationally, Karina has leveraged open science initiatives to propel her team onto the world stage, including successful participation in global drug discovery challenges such as Conscience's CACHE initiative for COVID-19 therapeutics. As Karina explains, open science has been key in providing access to critical data, software, and partnerships, democratizing opportunities for smaller labs like hers. Her story is a testament to how determined scientists, even from under-resourced environments, can foster innovation and make tangible contributions to global health. Karina dos Santos Machado holds a degree in Computer Engineering from the Universidade Federal de Rio Grande and a Master's and Ph.D. in Computer Science from the Pontifícia Universidade Católica of Rio Grande do Sul. Between 2018 and 2019, she worked as a postdoctoral fellowship in the NANO-D research group at INRIA in Grenoble, France. She is currently a Lecturer at FURG, working in the graduate programs in Health Sciences and Computer Science, where she coordinates the Computational Biology Laboratory. Her research focuses primarily on Bioinformatics and Data Science, including the following topics: Genomics, Machine Learning, Virtual Drug Screening, Molecular Docking, and Molecular Dynamics. Three Inspiring Take-aways from my conversation with Karina: Collaboration is a Superpower: In environments where resources are scarce, building bridges—within your university and beyond—makes it possible to tackle complex scientific problems. Don't hesitate to ask for help, offer your expertise, and create interdisciplinary teams; together, you go further. Open Science Levels the Field: By embracing open-source tools, sharing data, and participating in global challenges, you can give your work international visibility and validation, regardless of your location or funding status. Open science isn't just a philosophy; it's a passport to global research networks and impact. Your Local Challenges Have Global Resonance: The unique scientific questions you face in your community, like drug resistance in tuberculosis, are shared by the worldwide research community. Your perspective and commitment to real-world problems can drive both local solutions and contribute to advancing science on a global scale. Karina's journey proves that with innovation, community, and openness, you can thrive and lead in science, no matter where you start. If you're curious about AI, biosciences, or just want to see how resilient, creative science happens outside the “usual” power centers, this episode is a must-listen. Reach out to Karina on LinkedIn, and check out the episode for more wisdom! Let's build a more open, global scientific community together. See the resources section below for Daria Levina's links! This episode's resources: X | Karina Machado CONSCIENCE | Webpage CACHE Challenges | Webpage Thank you, Karina Machado! If you enjoyed this conversation with Karina, let her know by clicking the link below and leaving her a message on Linkedin: Send Karina Machado a thank you message on Linkedin! Click here to share your key take-away from this interview with David! Leave a review on Podchaser ! Support the show ! You might also like the following episodes: Daria Levina – Behind the Scenes of Graduate Admissions Morgan Foret – Demystifying Industry Careers Tina Persson –Leaving Academia and Embracing Industry Sylvie Lahaie – Navigating Stress and Anxiety in Graduate School
The first complete draft of the human genome was published back in 2003. Since then, researchers have worked both to improve the accuracy of human genetic data, and to expand its diversity, looking at the genetics of people from many different backgrounds. Three genetics experts join Host Ira Flatow to talk about a recent close examination of the genomes of 65 individuals from around the world, and how it may help researchers get a better understanding of genomic functioning and diversity.Guests:Dr. Christine Beck is an associate professor of genetics and genome sciences in the University of Connecticut Health Center and the Jackson Laboratory.Dr. Glennis Logsdon is an assistant professor of genetics and a core member of the Epigenetics Institute at the University of Pennsylvania.Dr. Adam Philippy is a Senior Investigator in the Center for Genomics and Data Science Research at the National Human Genome Research Institute at the NIH.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of The Dairy Podcast Show, Dr. Hinayah Rojas, from Purdue University, shares valuable insights into the rapidly evolving field of genomics in dairy cattle. Dr. Rojas breaks down the challenges and opportunities presented by longitudinal traits like milk production, discussing how genomic tools are helping to boost sustainability across the industry. Additionally, Dr. Rojas offers advice on balancing motherhood with a demanding professional life. Listen now on all major platforms!"The lactation curve is complex, but genomics allows us to select animals not only for higher milk production but also for better lactation persistence."Meet the guest: Dr. Hinayah Rojas de Oliveira is an Assistant Professor of Genomics and Animal Breeding at Purdue University. She holds a PhD in Animal Sciences, focusing on Genetics and Animal Breeding, from the Federal University of Viçosa in Brazil. Dr. Rojas has completed postdoctoral work at the University of Guelph and Purdue University and previously worked as a Geneticist at Lactanet Canada. Her research aims to develop statistical models that maximize genetic progress while preserving diversity in livestock species.Liked this one? Don't stop now — Here's what we think you'll love!What you'll learn:(00:00) Highlight(01:30) Introduction(02:35) Dr. Rojas's journey(08:52) Genomics in dairy cattle(11:55) Longitudinal traits(14:30) Genomic & efficiency(17:11) Sustainability & genomics(28:35) Final questionsThe Dairy Podcast Show is trusted and supported by innovative companies like:* Adisseo* Lallemand* Priority IAC* Evonik- ICC- AHV- Protekta- Natural Biologics- SmaXtec- Berg + Schmidt- dsm-firmenich
Scientists are beginning to understand that ageing is not a simply linear process. Instead, recent research appears to show that we age in three accelerated bursts; at about 40, 60 and 80 years old. To find out what might be going on, Ian Sample hears from Prof Michael Snyder, the director of the Center for Genomics and Personalised Medicine at Stanford University School of Medicine, who explains what the drivers of these bursts of ageing could be, and how they might be counteracted You can support the Guardian at theguardian.com/fullstorysupport
Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The science behind your garden hydrangeas involves far more than just planting and watering. Dr. Lisa Alexander, a research geneticist with the USDA Agricultural Research Service, takes us on a fascinating journey from her first days pollinating chestnut trees in a 70-foot bucket truck to her current work revolutionizing hydrangea breeding at the National Arboretum.Working from the heart of Tennessee's nursery country, Dr. Alexander explains how she's mapping the genetic diversity of oakleaf hydrangea across its six-state native range. Her team has identified six distinct genetic populations, some containing rare genes that might help plants survive drought or cold temperatures. This groundbreaking research comes at a critical time – they've discovered that urbanization has already caused these beautiful native plants to disappear from many previously recorded locations.The economic stakes are significant. Hydrangeas represent a $155 million industry, ranking as the second best-selling woody shrub behind roses. By understanding the genetic blueprint controlling traits like plant size, flower structure, and environmental adaptations, breeders can develop improved varieties that combine beauty with resilience.Dr. Alexander also discusses the exciting launch of "Hort Genomes" – a new initiative creating a dedicated home for specialty crop genomic data within the Journal of the American Society for Horticultural Science. This resource will accelerate research across horticultural fields by centralizing crucial genetic information previously scattered across publications or unavailable to the scientific community.Whether you're a backyard gardener admiring your hydrangeas or a scientist breeding the next generation of ornamental plants, this episode reveals the remarkable intersection of traditional horticulture with cutting-edge genomics that's shaping the future of our gardens.Read the JASHS article “Precipitation, Temperature, and Population Structure Influence Genetic Diversity of Oakleaf Hydrangea Throughout Its Native Range” at https://www.doi.org/10.21273/JASHS05255-22.Learn more about the American Society for Horticultural Science (ASHS) at https://ashs.org/.HortTechnology, HortScience and the Journal of the American Society for Horticultural Science are all open-access and peer-reviewed journals, published by the American Society of Horticultural Science (ASHS). Find them at journals.ashs.org.Consider becoming an ASHS member at https://ashs.org/page/Becomeamember!You can also find the official webpage for Plants, People, Science at ashs.org/plantspeoplesciencepodcast, and we encourage you to send us feedback or suggestions at https://ashs.org/webinarpodcastsuggestion. Podcast transcripts are available at https://plantspeoplescience.buzzsprout.com.On LinkedIn find Sam Humphrey at linkedin.com/in/samson-humphrey. Curt Rom is at https://www.linkedin.com/in/curt-rom-611085134/. Lena Wilson is at https://www.linkedin.com/in/lena-wilson-2531a5141/. Thank you for listening! ...
After Chris Walkland's dairy market update this week, Ben Eagle is joined by Kevin Ziemba, Global Applied Genetic Consulting Manager at STGenetics (parent company of Cogent Breeding) and Steve West, Senior Consultant with Kite to explore the latest in genetics and genomics in dairy farming. They discuss the financial benefits of breeding for Ecofeed to improve feed efficiency and profitability, as well as how to build a genetic strategy to best fit your business. They also discuss the newly discovered gene responsible for muscle weakness in calves and the impact this could have. Please note: The information provided during this podcast has been prepared for general informational purposes only and does not constitute advice. The information must not be relied upon for any purpose and no representation or warranty is given as to its accuracy, completeness or otherwise. Any reference to other organisations, businesses or products during the podcast are not endorsements or recommendations of Dairy Consulting Ltd or its affiliated companies. The views of the presenter are personal and may not be the views of Dairy Consulting Ltd. The contents of this podcast are the copyright of Dairy Consulting Ltd.
Scientists are beginning to understand that ageing is not a simply linear process. Instead, recent research appears to show that we age in three accelerated bursts; at about 40, 60 and 80 years old. To find out what might be going on, Ian Sample hears from Prof Michael Snyder, the director of the Center for Genomics and Personalised Medicine at Stanford University School of Medicine, who explains what the drivers of these bursts of ageing could be, and how they might be counteracted. Help support our independent journalism at theguardian.com/sciencepod
Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The New World Order, Agenda 2030, Agenda 2050, The Great Reset and Rise of The 4IR
Intelligence Notes: 4IR Genomics: AI Engineered Genetic Injections (Biomedical-Vaccine Warfare). Days of Noah Tech/ Fallen Watcher Technologies/ Augmentation via Transhumanism/ Biblical Eschatology (Genesis 6/ Matthew 24 ) Nephilim Tech, Giants , Hybrids, Genetic Monsters. Welcome to the: (Great Biological Reset).
Manifold has its own Discord channel! https://discord.gg/dvcHS6NXThe purpose of the channel is to create a community of listeners with shared interests. It developed from a series of in-person meetups with Steve in cities like SF, NYC, Singapore, Beijing, Shanghai.Chapter markers:(00:00) - Manifold Discord Channel, Live Q&A (02:36) - Genomics and Predictive Genetics (09:28) - Trump Administration, Epstein, and Political Commentary (29:42) - Missile Defense Systems: Historical Challenges and Modern Realities (36:48) - Failures and Cover-Ups in Missile Defense (45:23) - Developing Intellectual Taste and Productivity Tips Links related to Q&A:Best genomic predictor for cognitive ability: https://x.com/hsu_steve/status/1936401098345980207Ted Postol on missile defense: https://www.manifold1.com/episodes/theodore-a-postol-nuclear-weapons-missile-technology-and-u-s-diplomacy-12Sputnik moment: https://x.com/hsu_steve/status/1873541234125316367China-US comparisons:https://www.manifold1.com/episodes/letter-from-beijing-with-han-feizi-72https://www.manifold1.com/episodes/letter-from-shanghai-reflections-on-china-in-2024-73https://x.com/hsu_steve/status/1934216476560388250Music used with permission from Blade Runner Blues Livestream improvisation by State Azure.–Steve Hsu is Professor of Theoretical Physics and of Computational Mathematics, Science, and Engineering at Michigan State University. Previously, he was Senior Vice President for Research and Innovation at MSU and Director of the Institute of Theoretical Science at the University of Oregon. Hsu is a startup founder (SuperFocus.ai, SafeWeb, Genomic Prediction, Othram) and advisor to venture capital and other investment firms. He was educated at Caltech and Berkeley, was a Harvard Junior Fellow, and has held faculty positions at Yale, the University of Oregon, and MSU. Please send any questions or suggestions to manifold1podcast@gmail.com or Steve on X @hsu_steve.
Dr. Anne Marie Morse walks into the studio like a one-woman Jersey Broadway show and leaves behind the best damn TED Talk you've never heard. She's a neurologist, sleep medicine doc, narcolepsy expert, founder of D.A.M.M. Good Sleep, and full-time myth buster in a white coat. We talk about why sleep isn't a luxury, why your mattress does matter, and how melatonin is the new Flintstones vitamin with a marketing budget. We unpack the BS around sleep hygiene, blow up the medical gaslighting around “disorders,” and dig into how a former aspiring butterfly became one of the loudest voices for patient-centered science. Also: naps, kids, burnout, CPAPs, co-sleeping, airport pods, the DeLorean, and Carl Sagan. If you think you're getting by on five hours of sleep and vibes, you're not. This episode will make you want to take a nap—and then call your doctor.RELATED LINKSdammgoodsleep.com: https://www.dammgoodsleep.comLinkedIn: https://www.linkedin.com/in/anne-marie-morse-753b2821/Instagram: https://www.instagram.com/dammgoodsleepDocWire News Author Page: https://www.docwirenews.com/author/anne-marie-morseSleep Review Interview: https://sleepreviewmag.com/practice-management/marketing/word-of-mouth/sleep-advocacy-anne-marie-morse/Geisinger Bio: https://providers.geisinger.org/provider/anne-marie-morse/756868SWHR Profile: https://swhr.org/team/anne-marie-morse-do-faasm/FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q
We're back on the genetic evaluation theme with Peta Bradley, Operations Manager at Sheep Genetics, to talk all things sheep genetics and the exciting changes that are happening at MLA in terms of bringing the two LAMBPLAN databases together. Peta also discusses the evolution of the Sheep Genetics genetic evaluation over the years, the crucial role of genomics as well as phenotypes and a current reference population, as well as her ice-swimming journey! Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE
We might all have some sort of addiction. Jeremy Lipkowitz is a former Buddhist monk and now helps people beat addictions, specifically porn addiction. He also suffered himself and overcame a porn addiction. A Duke graduate of Genetics and Genomics, struggling with his own addictions suffering shame and self judgement, he decided to help others. After studying with Buddhists monks in Mynamar he deepened his mindfulness practice and started his lifelong commitment to service. On this show we explore all types of addictions such as shopping, digital, porn and other self sabotaging addictions, why they happen and how to reclaim your life, if you are an addict.
Scientific Sense ® by Gill Eapen: Prof. Trey Ideker is Professor of Medicine, Bioengineering and Computer Science, and former Chief of Genetics, at the University of California San Diego (UCSD). He is also the Director of the Bridge2AI Functional Genomics Data Generation Program and Co-Director of the Cancer Cell Map Initiative. Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1
Gigi Robinson grew up with Ehlers-Danlos syndrome, a disease that turns your joints into overcooked spaghetti. Instead of letting it sideline her, she built a career out of telling the truth about invisible illness. We talk about what it takes to grow up faster than you should, why chronic illness is the worst unpaid internship, and how she turned her story into a business. You'll hear about her days schlepping to physical therapy before sunrise, documenting the sterile absurdity of waiting rooms, and finding purpose in the mess. Gigi's not interested in pity or polished narratives. She wants you to see what resilience really looks like, even when it's ugly. If you think you know what an influencer does, think again. This conversation will challenge your assumptions about work, health, and what it means to be seen.RELATED LINKSGigi Robinson Website: https://www.gigirobinson.comLinkedIn: https://www.linkedin.com/in/gigirobinsonInstagram: https://www.instagram.com/itsgigirobinsonTikTok: @itsgigirobinsonA Kids Book About Chronic Illness: https://akidsco.com/products/a-kids-book-about-chronic-illnessFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
This episode features Dr. James Lu, CEO and Co-founder of Helix, discussing how precision medicine is evolving from specialty use to becoming a foundational element of mainstream healthcare. He explores the infrastructure, partnerships, and mindset shifts needed for health systems to scale genomic data and realize its full value.This episode is sponsored by Helix.
In this special episode of The Dairy Podcast Show, celebrating Cow Appreciation Day, Dr. Michael Schutz, Head of the Department of Animal Science at the University of Minnesota, shares updates on dairy cattle genetics and herd management. He covers everything from breakthroughs in genomics to colostrum management and industry-wide shifts in dairy science education and practice. Tune in now on your favorite podcast platform!"Computing capacity has revolutionized genetic evaluations, allowing us to manage data on a scale unimaginable decades ago."Meet the guest: Dr. Michael Schutz is the Department Head of Animal Science at the University of Minnesota. With a BS and MS in Animal Science from the University of Minnesota and a Ph.D. in Dairy Cattle Genetics from Iowa State University, he brings decades of experience in dairy cattle research and extension programs. A pioneer in dairy genetics, Dr. Schutz continues to lead efforts in education and innovation.Liked this one? Don't stop now — Here's what we think you'll love!What you'll learn:(00:00) Highlight(01:26) Introduction(04:00) Dairy extension(13:22) Herd management(17:07) Evolution in education(19:43) Colostrum quality(26:16) Computing capacity & genetics(32:54) Final three questionsThe Dairy Podcast Show is trusted and supported by innovative companies like:* Adisseo* Lallemand* Priority IAC* Evonik- SmaXtec- Berg + Schmidt- dsm-firmenich- Scoular- ICC- AHV- Protekta- Natural Biologics
Dr. Hao Nguyen presents focal therapy as a promising treatment option for carefully selected prostate cancer patients, especially those with intermediate-risk, localized disease. Unlike whole-gland treatments, focal therapy targets only the tumor while preserving healthy tissue, reducing the risk of side effects like urinary or sexual dysfunction. UCSF offers multiple approaches—high-intensity focused ultrasound, cryotherapy, and irreversible electroporation—selected based on tumor location and anatomy. Dr. Nguyen emphasizes the importance of precise imaging, MRI fusion biopsy, and genomic testing for patient selection and treatment planning. Early outcomes show encouraging results, with most patients avoiding surgery or radiation within two years and maintaining quality of life. While not yet standard first-line care, focal therapy is gaining traction through research and expert consensus. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40804]
Dr. Hao Nguyen presents focal therapy as a promising treatment option for carefully selected prostate cancer patients, especially those with intermediate-risk, localized disease. Unlike whole-gland treatments, focal therapy targets only the tumor while preserving healthy tissue, reducing the risk of side effects like urinary or sexual dysfunction. UCSF offers multiple approaches—high-intensity focused ultrasound, cryotherapy, and irreversible electroporation—selected based on tumor location and anatomy. Dr. Nguyen emphasizes the importance of precise imaging, MRI fusion biopsy, and genomic testing for patient selection and treatment planning. Early outcomes show encouraging results, with most patients avoiding surgery or radiation within two years and maintaining quality of life. While not yet standard first-line care, focal therapy is gaining traction through research and expert consensus. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40804]
Dr. Hao Nguyen presents focal therapy as a promising treatment option for carefully selected prostate cancer patients, especially those with intermediate-risk, localized disease. Unlike whole-gland treatments, focal therapy targets only the tumor while preserving healthy tissue, reducing the risk of side effects like urinary or sexual dysfunction. UCSF offers multiple approaches—high-intensity focused ultrasound, cryotherapy, and irreversible electroporation—selected based on tumor location and anatomy. Dr. Nguyen emphasizes the importance of precise imaging, MRI fusion biopsy, and genomic testing for patient selection and treatment planning. Early outcomes show encouraging results, with most patients avoiding surgery or radiation within two years and maintaining quality of life. While not yet standard first-line care, focal therapy is gaining traction through research and expert consensus. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40804]
Dr. Hao Nguyen presents focal therapy as a promising treatment option for carefully selected prostate cancer patients, especially those with intermediate-risk, localized disease. Unlike whole-gland treatments, focal therapy targets only the tumor while preserving healthy tissue, reducing the risk of side effects like urinary or sexual dysfunction. UCSF offers multiple approaches—high-intensity focused ultrasound, cryotherapy, and irreversible electroporation—selected based on tumor location and anatomy. Dr. Nguyen emphasizes the importance of precise imaging, MRI fusion biopsy, and genomic testing for patient selection and treatment planning. Early outcomes show encouraging results, with most patients avoiding surgery or radiation within two years and maintaining quality of life. While not yet standard first-line care, focal therapy is gaining traction through research and expert consensus. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40804]
Episode Description:If you've ever wondered what happens when a Bronx-born pediatric nurse with stage 4 colon cancer survives, raises a kid, becomes a policy shark, and fights like hell for the ignored, meet Vanessa Ghigliotty. She's not inspirational. She's a bulldozer. We go way back—like pre-Stupid Cancer back—when there was no “young adult cancer movement,” just a handful of pissed-off survivors building something out of nothing. This episode is personal. Vanessa and I built the plane while flying it. She fought to be heard, showed up in chemo dragging her kid to IEP meetings, and never stopped screaming for the rest of us to get what we needed. We talk war stories, progress, side-eyeing advocacy fads, TikTok activism, gatekeeping, policy wins, and why being loud is still necessary. And yeah—she's a damn good mom. Probably a better one than you. You'll laugh. You'll cry. You'll want to scream into a pillow. Come for the nostalgia. Stay for the righteous anger and iced coffee.RELATED LINKSVanessa on LinkedInColorectal Cancer Alliance: Vanessa's StoryZenOnco Interview with VanessaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Should I snack? Is snacking healthy? What about snacks through the day? These are some good questions that Sandra often fields from clients, and today, Rob and Sandra discuss timing and quality of snacks, plus, hunger cues, and the gene that 2/5 people in the population have that propels you to eat between meals. This one is more than a snack pack and is loaded with great information to take in and digest. Episodes references and mentioned, include:Ep 112 How to Stop Food Addiction with Dr. Vera Tarman https://youtu.be/1ZYtoNIxJh4?si=2Y1AdHZ1PyFcLaDLEp 75 Eating for Your Genes with Hilit Milner, RD Sunrise by HM https://youtu.be/fPptHnMqHiM?si=MUGPx6EOyHGZg1HuEp 109 Genomics in the Kitchen with Amanda Archibald, RD https://youtu.be/ZkvC0LDTRvI?si=CjiIsVapC4vLXBl1Nutrition Nuggets 32High Protein, Low Carb Snacks (20 options) https://youtu.be/kg2MI2pJs_U?si=dReLB8dvgGs1bXm1Ep 171 Break the Fast and Fuel Your Day https://youtu.be/5SWUgc1j2m8?si=mPzGnvTTFpmijOd3Ep 180 Navigating GLP-1 Medications with Ana Reisdorf, RD https://youtu.be/yR9rmLwedp8?si=5e2wfTC3U5I0GTgtEp 152 Ozempic and Weight Loss Medications - Get the Skinny with Rhonda Krickman, RD https://youtu.be/W5YHRtIliwE?si=a-BBlZ7Tbboz313fEp 101 Ozempic - Case Study https://youtu.be/nxpaQ0jc8NY?si=zHZHfeQAnq9lr8d1Ep 74 Craving Change - Wendy Shah, RD https://youtu.be/NOlCc7eqsj0?si=4w4JXUV4134jpOQQNutrition Nuggets 82 Appetite vs Hunger - What's the Difference https://youtu.be/-6C3S4KWfMo?si=KlH1D0eqNjgvWuZdFor more information on Nutrigenomix, head over to the Nutrigenomix website. https://nutrigenomix.com/aboutSandra is a practitioner and can help support you to have your 'eating for your genes' DNA test done through Nutrigenomix. Send us a message at mywifetherd@gmail.com with 'genes' in the subject line to learn more.Enjoying the show? Consider leaving a 5 star review, and/or sharing this episode with your friends and family :)Sign up for our newsletter on our website for weekly updates and other fun info. You can also visit our social media pages. We're on Facebook, Instagram, and YouTube.Your support helps fuel the stoke and keeps the show going strong every week. Thanks!Website: www.mywifethedietitian.comEmail: mywifetherd@gmail.com
UCSF oncologist Dr. Jonathan Chou discusses how genetics and genomics are transforming the diagnosis and treatment of prostate cancer. He explains how inherited and acquired mutations—especially in DNA repair genes like BRCA2—can impact both cancer risk and treatment decisions. Dr. Chou outlines how UCSF researchers use tumor and blood-based biopsies to identify key mutations and genomic features that help tailor care for each patient. Examples include how genomic scores can predict response to radiation and how targeted therapies like PARP inhibitors benefit patients with specific mutations. The talk highlights the growing role of precision medicine in guiding individualized treatment plans based on the unique genetic profile of each patient's cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40798]
UCSF oncologist Dr. Jonathan Chou discusses how genetics and genomics are transforming the diagnosis and treatment of prostate cancer. He explains how inherited and acquired mutations—especially in DNA repair genes like BRCA2—can impact both cancer risk and treatment decisions. Dr. Chou outlines how UCSF researchers use tumor and blood-based biopsies to identify key mutations and genomic features that help tailor care for each patient. Examples include how genomic scores can predict response to radiation and how targeted therapies like PARP inhibitors benefit patients with specific mutations. The talk highlights the growing role of precision medicine in guiding individualized treatment plans based on the unique genetic profile of each patient's cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40798]
UCSF oncologist Dr. Jonathan Chou discusses how genetics and genomics are transforming the diagnosis and treatment of prostate cancer. He explains how inherited and acquired mutations—especially in DNA repair genes like BRCA2—can impact both cancer risk and treatment decisions. Dr. Chou outlines how UCSF researchers use tumor and blood-based biopsies to identify key mutations and genomic features that help tailor care for each patient. Examples include how genomic scores can predict response to radiation and how targeted therapies like PARP inhibitors benefit patients with specific mutations. The talk highlights the growing role of precision medicine in guiding individualized treatment plans based on the unique genetic profile of each patient's cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40798]
The Smart 7 is an award winning daily podcast, in association with METRO that gives you everything you need to know in 7 minutes, at 7am, 7 days a week...With over 18 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and the Sunday 7 won a Gold Award as “Best Conversation Starter” in the International Signal Podcast Awards If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests:GuestsMartin Kulldorf - Professor of Medicine and member of ACIP Kim Schrier - Democratic Congresswoman, WAProfessor Elizabeth Whittaker - Paediatric Expert in Infectious Diseases Will Guyatt - The Smart 7's Tech Guru Doctor Helen O'Neill - Associate Professor of Molecular Genetics at University College LondonProfessor Rameen Shakur - Professor of Genomics at the University of Brighton William O'Mullaine Associate Director for Data Production at the Vera C Rubin Observatory, Chile Elon Musk - Founder and CEO of NeuralinkPaolo Ardoino - CEO of Tether T - a car thief interviewed by Channel 4's DispatchesIan Thwaites - Police Constable from the Port of Dover Police Anthony Alexander - Peace Park Foundations Programme Manager Contact us over @TheSmart7pod or visit www.thesmart7.com or find out more at www.metro.co.uk Presented by Ciara Revins, written by Liam Thompson, researched by Lucie Lewis and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.
UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]
UCSF's Dr. Rahul Aggarwal explains the role of clinical trials in advancing prostate cancer treatment and how trial design is evolving to match today's more personalized approaches. He highlights how UCSF has contributed to major prostate cancer therapies and emphasizes the importance of genetic and genomic testing in identifying suitable trials for each patient. Dr. Aggarwal explains the different trial phases, clarifies common myths—such as concerns about placebos—and stresses that trials are considered at every stage of disease. He also discusses efforts to improve access, affordability, and diversity in trial participation, including regional partnerships and digital matching tools. The talk encourages patients to be informed and proactive when considering clinical trials as part of their treatment plan. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40800]
What's the best gift you can give? To the millions of people whose lives have been saved by complete strangers, the answer would be simple: blood. But what exactly happens when blood has been donated, and how do we know it is safe? We chat to Dr Richard Mayne from Oxford's Experimental Medicine Division about genomics, Next-Generation Sequencing, blood screening (...and Star Trek). Could you be a blood-donating hero? Blood stocks are currently critically low, with the NHS Blood and Transplant (NHSBT) group in urgent need of new donors. Click here, and you'll be on your way to saving lives: https://www.blood.co.uk/news-and-campaigns/campaigns/blood-donor-appeal/
Risa Arin doesn't just talk about health literacy. She built the damn platform. As founder and CEO of XpertPatient.com (yes, expert with no E), Risa's taking a wrecking ball to how cancer education is delivered. A Cornell alum, cancer caregiver, and ex-agency insider who once sold Doritos to teens, she now applies that same marketing muscle to helping patients actually understand the garbage fire that is our healthcare system. We talk about why she left the “complacent social safety” of agency life, how her mom unknowingly used her own site during treatment, what it's like to pitch cancer education after someone pitches warm cookies, and why healthcare should come with a map, a translator, and a refund policy. Risa brings data, chutzpah, and Murphy Brown energy to the conversation—and you'll leave smarter, angrier, and maybe even a little more hopeful.RELATED LINKS• XpertPatient.com• Risa Arin on LinkedIn• XpertPatient & Antidote Partnership• XpertPatient Featured on KTLA• 2024 Health Award BioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Since the 1800s, tuberculosis (TB) has been responsible for an estimated 1 billion deaths. In New Zealand today, we don't get many cases of TB, but worldwide it is the leading infectious disease killer. In the early 1900s a TB vaccine was developed. Called the BCG vaccine, it's still used today. While it is the best TB vaccine we have, it's not actually great at preventing TB infection, only providing some protection for the youngest of patients. However, scientists have discovered that the BCG vaccine can boost people's immune systems in other ways. Now researchers at the Malaghan Institute in Wellington are investigating these findings further. Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.Guests:Dr Kerry Hilligan, Malaghan InstituteRebecca Palmer, Malaghan InstituteLearn more:In 2017, Alison Ballance reported on the looming antimicrobial resistance crisis, with drug-resistant TB part of the problem.Other Our Changing World episodes about research at the Malaghan Institute include this 2024 episode on a new way to target rising stomach cancer rates, and this 2022 episode on next-generation cancer therapies.In 2021, Claire Concannon covered mRNA vaccine technology.The What if...? Genomics in Aotearoa series explores the different ways genomics is transforming different sectors, including infectious disease medicine.Go to this episode on rnz.co.nz for more details
Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In celebration of Pride Month, we're sharing two stories about coming out with the help of science. Part 1: After years of struggling with their gender identity, Parker Sublette finds inspiration in marine life. Part 2: Bullied as a kid for the sound of his voice, Garret Glinka begins to reclaim his confidence thanks to biology class. Parker Sublette is a comedian and speculative fiction writer living in Brooklyn, New York. She can usually be found scrambling around the city looking for any stage that will have her, or at home with her roommates and their two cats. Parker also sometimes hosts an open-mic in Bushwick, you can find her @parks_jokez on instagram. Garret Glinka: I wear two hats: one as a businessman with half a Master's in Business, and the other as a scientist, with another half in Biotechnology and Genomics, complemented by a Bachelor's in Biological Sciences. My background allows me to bridge the administrative and scientific worlds. Over the past six years, I've honed my expertise as a laboratory professional in both corporate and academic settings, helping operate and set up five laboratories domestically/internationally. I've been a technician, team leader, supervisor, and lab manager. As a member of the queer community, I bring kindness, authenticity, vulnerability, and positive influence to my leadership style. Now at Columbia University's Neuroscience Institute, I manage two labs, lead the Gender and Inclusion Mentoring Program, and coordinate the Lab Liaison Group, ensuring communication across the institute's departments and other lab managers. When I'm not dissecting Drosophila in New York City, or out to eat with Jersey City friends, I retreat to my family's farm in central New Jersey. There you'll find me tending to our goats and chickens, inspecting the crops, or racing dirt bikes with my three-year-old nephew, Jay. My life is a dynamic blend of science, leadership, community, and family, each enriching the other in unexpected ways. Learn more about your ad choices. Visit megaphone.fm/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In celebration of Pride Month, we're sharing two stories about coming out with the help of science. Part 1: After years of struggling with their gender identity, Parker Sublette finds inspiration in marine life. Part 2: Bullied as a kid for the sound of his voice, Garret Glinka begins to reclaim his confidence thanks to biology class. Parker Sublette is a comedian and speculative fiction writer living in Brooklyn, New York. She can usually be found scrambling around the city looking for any stage that will have her, or at home with her roommates and their two cats. Parker also sometimes hosts an open-mic in Bushwick, you can find her @parks_jokez on instagram. Garret Glinka: I wear two hats: one as a businessman with half a Master's in Business, and the other as a scientist, with another half in Biotechnology and Genomics, complemented by a Bachelor's in Biological Sciences. My background allows me to bridge the administrative and scientific worlds. Over the past six years, I've honed my expertise as a laboratory professional in both corporate and academic settings, helping operate and set up five laboratories domestically/internationally. I've been a technician, team leader, supervisor, and lab manager. As a member of the queer community, I bring kindness, authenticity, vulnerability, and positive influence to my leadership style. Now at Columbia University's Neuroscience Institute, I manage two labs, lead the Gender and Inclusion Mentoring Program, and coordinate the Lab Liaison Group, ensuring communication across the institute's departments and other lab managers. When I'm not dissecting Drosophila in New York City, or out to eat with Jersey City friends, I retreat to my family's farm in central New Jersey. There you'll find me tending to our goats and chickens, inspecting the crops, or racing dirt bikes with my three-year-old nephew, Jay. My life is a dynamic blend of science, leadership, community, and family, each enriching the other in unexpected ways. Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode: 2934 Reading the Molecules of Life. Today, we read the molecules of life.
Erica Campbell walked away from corporate life, took a hard left from the British Embassy, and found her calling writing checks for families nobody else sees. As Executive Director of Pinky Swear Foundation, she doesn't waste time on fluff. Her team pays rent, fills gas tanks, and gives sick kids' parents the one thing they don't have—time. Then, breast cancer hit her. She became the patient. Wrote a book about it. Didn't sugarcoat a damn thing. We talk about parking fees, grief, nonprofit burnout, and how the hell you decide which families get help and which don't. Also: AOL handles, John Hughes, and letters from strangers that make you cry. Erica is part Punky Brewster, part Rosie the Robot, and part Lisa Simpson—with just enough GenX Long Island sarcasm to make it all land. This one sticks.RELATED LINKSPinky Swear FoundationThe Mastectomy I Always Wanted (Book)Erica on LinkedInThink & Link: Erica Campbell“Like the Tale of a Starfish” - Blog Post“Cancer Diagnosis, Messy Life, Financial Support” - Blog PostFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Allyson with a Y. Ocean with two Ls. And zero chill when it comes to changing the face of cancer care. Dr. Allyson Ocean has been quietly—loudly—at the center of every major cancer breakthrough, nonprofit board, and science-backed gut punch you didn't know you needed to hear. In this episode, she joins me in-studio for a conversation two decades in the making. We talk twin life, genetics, mitochondrial disease, and why she skipped the Doublemint Twins commercial but still ended up as one of the most recognizable forces in oncology. We cover her nonprofit hits, from Michael's Mission to Let's Win Pancreatic Cancer to launching the American Jewish Medical Association—yes, that's a thing now. We get personal about compassion in medicine, burnout, bad food science, and microplastics in your blood. She also drops the kind of wisdom only someone with her résumé and sarcasm can. It's raw. It's real. It's the kind of conversation we should've had 20 years ago—but better late than never.RELATED LINKS:– Dr. Allyson Ocean on LinkedIn– Let's Win Pancreatic Cancer– NovoCure Leadership Page– Michael's Mission– American Jewish Medical Association– The POLG Foundation– Cancer Buddy App (Bone Marrow and Cancer Foundation)– Dr. Ocean at OncLiveFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Sponsored by Invivyd, Inc.Nobody wants to hear about COVID-19 anymore. Especially not cancer patients. But if you've got a suppressed immune system thanks to chemo, radiation, stem cell transplants—or any of the other alphabet soup in your chart—then no, it's not over. It never was. While everyone else is getting sweaty at music festivals, you're still dodging a virus that could knock you flat.In this episode, Matthew Zachary and Matt Toresco say the quiet part out loud: many immunocompromised people may not even know they have options beyond vaccines. Why? Because the system doesn't bother to tell them. So we're doing it instead. We teamed up with Invivyd to help get the word out about tools other than vaccines that can help prevent COVID-19. We break down the why, the what, and the WTF of COVID-19 risk for cancer patients and why every oncologist should be talking about this.No fear-mongering. No sugarcoating. Just two guys with mics who've been through it and want to make sure you don't get blindsided. It's fast, funny, and furious—with actual facts. You've got more power than you think. Time to use it.RELATED LINKSExpand Their OptionsInvivydMatt Toresco on LinkedInOut of Patients podcastFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.